Status:
UNKNOWN
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Lead Sponsor:
Beijing Tsinghua Chang Gung Hospital
Conditions:
Fatty Liver Disease
Eligibility:
All Genders
18-75 years
Brief Summary
To investigate the prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among adults in China
Detailed Description
Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease all over the world (1). In early 2020, a new definition of MAFLD has been proposed and is becoming increasingly widel...
Eligibility Criteria
Inclusion
- Aged between 18 and 75, both sex;
- Able to sign informed consent.
Exclusion
- Pregnant women and those who are implanted with pacemakers, stents or any other metal devices.
Key Trial Info
Start Date :
June 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05421572
Start Date
June 10 2022
End Date
December 31 2022
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bejing Tsinghua Chang Gung Hospital
Beijing, Bejing, China, 100034